CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SANA — Sana Biotechnology, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,813,341
+$878,835 QoQ
Shares Held
1,379,181
+1.0% QoQ
Ownership
0.461%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. SANA ranks #139 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,813,341 | 1,379,181 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,934,506 | 1,366,148 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,695,293 | 1,399,335 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,517,598 | 1,272,563 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,965,257 | 1,086,175 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,791,390 | 1,066,304 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,722,114 | 1,056,512 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,359,039 | 1,047,846 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,145,853 | 942,464 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,235,100 | 823,510 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,055,246 | 748,835 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,830,192 | 731,316 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,023,709 | 675,119 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,866,581 | 570,820 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,574,610 | 651,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,809,214 | 634,869 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,855,588 | 599,625 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,055,557 | 612,053 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,206,157 | 594,713 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,124,588 | 582,797 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,470,880 | 227,410 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,639,561 | 168,496 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||